VBI Vaccines Inc. announced that it has entered into a stock purchase agreement with returning investor Brii Biosciences Limited to issue 1 common share at an issue price of $3,000,00 for the gross proceeds of $3,000,000 on July 5, 2023. The Transaction is contingent upon the closing of a concurrent underwritten public offering for aggregate gross proceeds of at least $5,000,000.